Highlights The off-label use of low-dose naltrexone (LDN) is a potential drug intervention for the management of post-COVID conditions. LDN...
SMCI Ramsay Award recipient and new researcher to the field. Cognitive impairment also called “brain fog” is present in up to 85% of the patients...
Separate names with a comma.